|
PRDX3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.26023669067399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.12530010152068E-11 |
| Normal-vs-Stage2 |
5.64840000000233E-05 |
| Normal-vs-Stage3 |
2.42439999964539E-07 |
| Normal-vs-Stage4 |
1.540330E-03 |
| Stage1-vs-Stage2 |
2.381400E-01 |
| Stage1-vs-Stage3 |
9.270000E-01 |
| Stage1-vs-Stage4 |
3.119800E-01 |
| Stage2-vs-Stage3 |
3.598200E-01 |
| Stage2-vs-Stage4 |
9.030400E-01 |
| Stage3-vs-Stage4 |
4.025400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.58084697846562E-12 |
| Normal-vs-AfricanAmerican |
1.39219999972795E-07 |
| Normal-vs-Asian |
5.977200E-04 |
| Caucasian-vs-AfricanAmerican |
2.441600E-01 |
| Caucasian-vs-Asian |
6.804600E-01 |
| AfricanAmerican-vs-Asian |
4.501200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.84274817627283E-12 |
| Normal-vs-Female |
1.60259999715251E-08 |
| Male-vs-Female |
2.475600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.28079999331499E-09 |
| Normal-vs-Extreme_Weight |
4.84334794492725E-12 |
| Normal-vs-Obese |
3.72950004212669E-09 |
| Normal-vs-Extreme_Obese |
9.484400E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.427000E-01 |
| Normal_Weight-vs-Obese |
3.090600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.316200E-02 |
| Extreme_Weight-vs-Obese |
1.882000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.676780E-01 |
| Obese-vs-Extreme_Obese |
1.919380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.37669999999524E-05 |
| Normal-vs-Age(41-60Yrs) |
4.02170519109291E-11 |
| Normal-vs-Age(61-80Yrs) |
2.88770007905725E-10 |
| Normal-vs-Age(81-100Yrs) |
8.34399999982693E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.159800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.557800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.399200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.289600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.402000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.404000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.14506190587826E-12 |
| Normal-VS-Type2 PRCC |
7.76419999959366E-07 |
| Normal-VS-KIRP CIMP |
4.623200E-04 |
| Normal-VS-Unclassified PRCC |
1.26510000031388E-07 |
| Type1 PRCC-VS-Type2 PRCC |
7.958300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.697600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.390200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.362800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.319400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.585400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.79919995463496E-09 |
| Normal-vs-N1 |
1.13459999995236E-06 |
| Normal-vs-N2 |
3.021400E-04 |
| N0-vs-N1 |
7.180400E-01 |
| N0-vs-N2 |
5.547600E-01 |
| N1-vs-N2 |
4.594800E-01 |
|
|
